Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Urinary Retention Postoperative: full-pipeline trial registry

2 of 4 indexed Urinary Retention Postoperative trials are currently recruiting.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Urinary Retention Postoperative: 4 US clinical trials tracked, 2 recruiting.

Urinary Retention Postoperative is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), running 1 of these trials.

Enrollment posture brief

Registry condition urinary-retention-postoperative

OPEN 2 | RECR 50% | LATE 1 | EARLY 1 | RANK #4115 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Urinary Retention Postop (th…50%
Open-enrollment share among volume-matched conditions near Urinary Retention Postoperative

Urinary Retention Postoperative lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Urinary Retention Postoperative on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Urinary Retention Postoperative is recruiting above its size-band peers.

    2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Urinary Retention Postoperative records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Strict need to void following surgery Behavioral
1 trials
No Strict need to void following surgery Behavioral
1 trials
Choice of reversal agent (sugammadex or neostigmine [with muscaranic antagonist]) Drug
1 trials
Tamsulosin Drug
1 trials
Uroselective alpha-1-adrenergic receptor antagonist Drug
1 trials
Placebo Other
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Urinary Retention Postoperative trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Minnesota 1 trials
Maryland 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Urinary Retention Postoperative page

4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Urinary Retention Postoperative condition card totals 4 registered trials; most-linked intervention Strict need to void following surgery; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.